Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fexofenadine ANDA

This article was originally published in The Tan Sheet

Executive Summary

Dr. Reddy's Labs has filed ANDA for fexofenadine 30 mg, 60 mg and 180 mg, equivalent to Aventis' Allegra, firm says March 25. Aventis subsequently filed lawsuit in New Jersey federal court alleging patent infringement on six Orange Book patents, Dr. Reddy's notes. Firm will likely switch products in future; Hyderabad, India-based Dr. Reddy's recently sealed distribution deal with Leiner to expand foothold in U.S. OTC drug market (1"The Tan Sheet" March 3, 2003, p. 3)...
Advertisement

Related Content

Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal
Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS095283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel